Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism
This study has been completed.
Study NCT00123461 Information provided by Genzyme
First Received: July 21, 2005 Last Updated: July 28, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Secondary Hyperparathyroidism
Renal Failure
Chronic Renal Insufficiency
Additional conditions recognized in this trial
Hyperparathyroidism
Hyperparathyroidism, Secondary
Kidney Diseases
Kidney Failure
Kidney Failure, Chronic
Neoplasm Metastasis
Renal Insufficiency
Renal Insufficiency, Chronic
More general conditions related to this trial
Endocrine System Diseases
Neoplasms
Neoplastic Processes
Parathyroid Diseases
Pathologic Processes
Urologic Diseases
Additional drug interventions recognized in this trial
1 alpha-hydroxyergocalciferol
Ergocalciferols
More general drug interventions related to this trial
Bone Density Conservation Agents
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Vitamins
Sponsors listed in this trial
Genzyme
Back to top of Main Content
